SCHEMBL3801622

SCHEMBL3801622

C=CC(Cl)N1CCCCC1

nearest known ligand 0.31

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.31
MAPT P10636 1/20 0.31
HTT P42858 1/20 0.31
FDPS P14324 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11768323 1.00 LMNA (0.31) LMNAMAPTHTTFDPS
SCHEMBL11767128 1.00 LMNA (0.31) LMNAMAPTHTTFDPS
SCHEMBL5694538 0.75 CYP2D6 (0.35)
SCHEMBL10662577 0.75 ALDH1A1 (0.31)
SCHEMBL1120453 0.74 LMNA (0.45) LMNAMAPTHTTFDPS
SCHEMBL229258 0.74 LMNA (0.45) LMNAMAPTHTTFDPS
SCHEMBL22412645 0.74 LMNA (0.45) LMNAMAPTHTTFDPS
SCHEMBL11859960 0.73
Hydrochloric Acid SCHEMBL2704379 0.72 FDPS (0.33) FDPS
SCHEMBL45551 0.72 FDPS (0.33) FDPS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8747810-B2 Compositions and methods for imaging tissues, organs and tumors PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2014-06-10 US disclosed
US-20120269724-A1 COMPOSITIONS AND METHODS FOR IMAGING TISSUES, ORGANS AND TUMORS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2012-10-25 US disclosed
WO-2010144891-A1 COMPOSITIONS AND METHODS FOR IMAGING TISSUES, ORGANS AND TUMORS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2010-12-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120269724-A1 COMPOSITIONS AND METHODS FOR IMAGING TISSUES, ORGANS AND TUMORS SSTR3, TACR1, SSTR5 LMNA 4716/4885MAPT 3819/4885HTT 1807/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.